Medications
alemtuzumab
Monoclonal Antibodies
Approved use in
T-Cell Prolymphocytic Leukemia
cladribine
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
cytarabine
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
Famciclovir
Antiviral/Antineoplastic Agents
Approved use in
T-Cell Prolymphocytic Leukemia
ibrutinib
Tyrosine Kinase Inhibitors
Approved use in
T-Cell Prolymphocytic Leukemia
mitoxantrone
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
nelarabine
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
Olaparib (Lynparza)
Targeted Therapies
Approved use in
T-Cell Prolymphocytic Leukemia
pentostatin
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
ruxolitinib
Targeted Therapies
Approved use in
T-Cell Prolymphocytic Leukemia
Tofacitinib
Targeted Therapies
Approved use in
T-Cell Prolymphocytic Leukemia
trimethoprim
Chemotherapy Agents
Approved use in
T-Cell Prolymphocytic Leukemia
venetoclax
Targeted Therapies
Approved use in
T-Cell Prolymphocytic Leukemia